|
UBE2K expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.14652773123225E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.47402140177655E-13 |
| Normal-vs-Stage2 |
5.798000E-04 |
| Normal-vs-Stage3 |
2.15480000509416E-08 |
| Normal-vs-Stage4 |
3.959200E-01 |
| Stage1-vs-Stage2 |
3.270200E-01 |
| Stage1-vs-Stage3 |
9.347800E-01 |
| Stage1-vs-Stage4 |
2.088500E-02 |
| Stage2-vs-Stage3 |
3.336200E-01 |
| Stage2-vs-Stage4 |
2.129000E-01 |
| Stage3-vs-Stage4 |
1.038430E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.12643228078468E-12 |
| Normal-vs-AfricanAmerican |
5.45449999944658E-07 |
| Normal-vs-Asian |
3.633900E-04 |
| Caucasian-vs-AfricanAmerican |
2.594400E-01 |
| Caucasian-vs-Asian |
9.077200E-01 |
| AfricanAmerican-vs-Asian |
7.967200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.20823359597944E-13 |
| Normal-vs-Female |
2.49429999999995E-05 |
| Male-vs-Female |
1.459670E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.11609999995122E-06 |
| Normal-vs-Extreme_Weight |
1.97408756008599E-12 |
| Normal-vs-Obese |
1.03180000099456E-08 |
| Normal-vs-Extreme_Obese |
3.91290000001376E-06 |
| Normal_Weight-vs-Extreme_Weight |
2.030400E-01 |
| Normal_Weight-vs-Obese |
9.804000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.498600E-01 |
| Extreme_Weight-vs-Obese |
1.358560E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.191200E-01 |
| Obese-vs-Extreme_Obese |
5.938000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.74674999999791E-05 |
| Normal-vs-Age(41-60Yrs) |
3.57139995355027E-09 |
| Normal-vs-Age(61-80Yrs) |
1.78779213655389E-12 |
| Normal-vs-Age(81-100Yrs) |
3.06839999963948E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.134600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.397200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.487600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.122300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.563800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.507600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.79141162909491E-13 |
| Normal-VS-Type2 PRCC |
5.80570036490258E-10 |
| Normal-VS-KIRP CIMP |
1.774210E-01 |
| Normal-VS-Unclassified PRCC |
7.1609999996447E-07 |
| Type1 PRCC-VS-Type2 PRCC |
8.609000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.059800E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.486400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.614180E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.115600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.538800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.19824158875781E-14 |
| Normal-vs-N1 |
2.921400E-03 |
| Normal-vs-N2 |
4.299000E-01 |
| N0-vs-N1 |
6.776300E-02 |
| N0-vs-N2 |
6.243400E-01 |
| N1-vs-N2 |
9.860800E-01 |
|
|
